CELU — Celularity Inc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1752828 ·
Last close
$1.56
Market Cap
$50.62M
52W High
$2.55
52W Low
$0.56
ADV30
844,400
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 4,104,000 | -3,270,000 | -22,058,000 | -24,362,000 | 107,329,000 | 6,175,000 | 145,391,000 |
| Sep 2025 | 5,284,000 | 1,380,000 | -12,900,000 | -23,076,000 | 114,239,000 | 120,000 | 134,333,000 |
| Jun 2025 | 5,736,000 | 494,000 | -15,864,000 | -24,524,000 | 120,283,000 | 863,000 | 145,780,000 |
| Mar 2025 | 11,426,000 | 7,872,000 | -10,486,000 | -19,754,000 | 128,876,000 | 293,000 | 134,382,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-13,257,000
Investing CF
$0
Financing CF
$18,649,000
CapEx
—
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.74
As of
2026-10-05
Balance + Analyst (yfinance extras)
Retained Earnings
$-991,483,000
Inventory
$571,000
Receivables
$4,653,000
ST Investments
—
EBIT TTM
$-84,959,000
Pretax Income TTM
$-91,713,000
Interest Exp TTM
$6,754,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$18,970,000
EBITDA
$-53,897,000
Free Cash Flow
$-1,360,625
Enterprise Value
$119,631,624
Total Cash
$368,000
Total Debt
$68,080,000
Shares Out
32,449,767
Trailing EPS
$-2.73
Book Value
$-1.21
ROE
—
ROA
-32.3%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 26,550,000 | -61,308,000 | -91,716,000 | 107,329,000 | 145,391,000 | -38,062,000 | -13,254,000 |
| Dec 2024 | 54,220,000 | -38,551,000 | -57,892,000 | 132,682,000 | 123,845,000 | 8,837,000 | -6,401,000 |
| Dec 2023 | 22,771,000 | -76,479,000 | -196,295,000 | 143,889,000 | 102,929,000 | 40,960,000 | -38,685,000 |
| Dec 2022 | 17,975,000 | -148,267,000 | 14,192,000 | 401,066,000 | 202,165,000 | 198,901,000 | -137,876,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$26,550,000
NetIncome TTM
$-91,716,000
OpCashFlow TTM
—
Assets (Latest)
$114,239,000
Forward EPS
$-0.57
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $1.00 · spot: $1.56 · call volume: 85 · put volume: 7
Expected Move to 2026-10-16:
±$0.74
(47.44%) —
implied range
$0.82 –
$2.30
· ATM straddle on $1.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | $50.80M | $2.00 | — |
| ANVS | Annovis Bio, Inc. | $51.55M | $1.21 | — |
| ELTX | Elicio Therapeutics, Inc. | $49.67M | $1.89 | — |
| CLNN | Clene Inc. | $49.60M | $3.86 | — |
| ACET | Adicet Bio, Inc. | $52.52M | $5.61 | — |
News headlines (Yahoo Finance, 1h cache)
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
2026-09-30 15:57 · Yahoo
Celularity Announces Naveen Jain to Join Board of Directors
2026-09-29 12:30 · Yahoo
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
2026-09-24 13:15 · Yahoo
Celularity Signs U.S. Manufacturing Collaboration With Potential $300 Million Purchase Opportunity
2026-08-27 14:27 · Yahoo
Celularity Provides Update Regarding Nasdaq Listing Compliance
2026-08-25 23:59 · Yahoo
NexGel Files to Register 15.25 Million Shares From Note Conversions
2026-08-20 17:35 · Yahoo
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
2026-06-04 12:00 · Yahoo
Celularity Releases CEO Letter to Shareholders
2026-06-03 20:15 · Yahoo
Celularity Appoints Rick Gonzalez as Chief Commercial Officer
2026-06-03 12:00 · Yahoo
Celularity Receives Nasdaq Notice Regarding Form 10-Q
2026-05-29 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.